Dr. Reddy’s Q4 and FY16 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.07
May 12, 2016 9:19 AM EDTDr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.07, versus $0.46 reported last year. Revenue for the quarter came in at $567 billion, versus $584 billion reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More